Product Family · Hyaluronic-acid fillers

RHA® Collection

An HA filler collection often discussed for dynamic facial movement and resilience characteristics. Educational literacy only.

Product collectionResilient hyaluronic-acid filler familyModerate evidence baseVaries by product and indication

Product Family pages are educational. Quorenne does not recommend one product over another, provide dosing or technique, select providers, or determine whether any product is appropriate for you. Important Information · Scientific Philosophy · Editorial Standards

You may also want to understand

Ask about RHA® Collection

Suggested questions keep this page in mind. You can also ask anything else across Quorenne.

Open Ask Quorenne about RHA® Collection

What it is

The RHA® Collection includes HA gels designed with an emphasis on stretch and strength characteristics for dynamic facial areas, depending on the specific product and labeling.

Context. Commonly associated with Revance / Teoxane distribution contexts in U.S. education. This is identifying context—not an endorsement.

Typical U.S. cost

A reliable national cost range could not be confirmed.

Pricing varies by provider, location, treatment area, and treatment plan.

How it differs from other products in its category

Educational differentiation often focuses on dynamic rheology versus other HA families. That is a technical framing—not proof that RHA is better for every person or area.

Other educational pages in this family:

FDA-approved indications (general educational overview)

  • RHA products have specific FDA-approved indications for selected facial wrinkles and folds—check each product’s labeling.
  • Approved uses are not identical across every RHA product.

Always verify current product labeling. Quorenne does not reproduce full prescribing information.

Cosmetic and therapeutic uses

Cosmetic (high level)

  • Discussed for dynamic wrinkles and folds depending on product
  • Product choice remains clinician-directed

Therapeutic (high level)

  • Clinician-directed medical contexts only when applicable

Typical onset and duration

Typical onset. Often visible soon after treatment, with swelling affecting early appearance.

Typical duration. Duration conversations vary by product and area; individual longevity is not guaranteed.

Ranges are educational. Individual results cannot be predicted by Quorenne.

Factors affecting results

  • Product rheology and gel characteristics
  • Injection plane and technique chosen by the clinician
  • Individual anatomy, tissue quality, and healing
  • Amount used and treatment area
  • Aftercare and follow-up discussed with the clinician

What it does not do

  • Treat every form of aging or laxity
  • Guarantee symmetrical or permanent change
  • Replace neuromodulators for dynamic expression lines in every educational framing
  • Remove the need to discuss vascular risk and emergency protocols with a clinician

Risks and limitations

  • Swelling, bruising, tenderness, and temporary lumps
  • Infection or inflammatory responses
  • Vascular occlusion is uncommon but serious—seek urgent care for vision changes or severe pain
  • Migration, Tyndall effect, or contour irregularities depending on product and placement
  • Allergy or delayed nodules in some contexts

Common misconceptions

  • Fillers always look unnatural.
  • One brand is universally best for every face.
  • Filler permanently stays exactly where it was placed forever.
  • Fillers replace a full medical evaluation.
  • Resilient HA means zero risk of lumps or vascular events.

Questions to ask your clinician

  • What are your training and experience with this product?
  • Is the planned use approved or cleared for this indication, or discussed off-label?
  • How does this product compare with others in this category for my goals?
  • What results are realistic for someone with my anatomy and medical history?
  • What risks are most relevant to my skin tone, medications, and medical history?
  • What recovery should I expect, and how are complications recognized and managed?
  • Who will perform the procedure, and what follow-up is available?
  • What alternatives should I consider before deciding?

Evidence and references

RHA products have clinical programs supporting labeled indications. Quorenne does not elevate the collection above other HA families.

  • FDA product labeling and approval summaries (indication-specific) — Indications and language change; verify current labeling.
  • Dermatology / aesthetic medicine society educational materials
  • Quorenne editorial synthesis for consumer education

Reviewed. 2026-08-05

Continue Understanding

These resources build on what you’ve just learned.

Learn Next

A calm learning path from this topic — not a random set of links.

  1. 1Continue in Skin Lab
  2. 2Explore skin concerns
  3. 3Ask Quorenne

Ask Quorenne →